| 000 | 01617nam a22004218a 4500 | ||
|---|---|---|---|
| 005 | 20250919010757.0 | ||
| 006 | m|||||o||d|||||||| | ||
| 007 | cr|||||||||||| | ||
| 008 | 160223r2012||||enk s ||1 0|eng|d | ||
| 020 | _a9780511977640 (ebook) | ||
| 020 | _z9780521766067 (hardback) | ||
| 035 | _a(OCoLC)812178332 | ||
| 035 | _a(UkCbUP)CR9780511977640 | ||
| 039 | 9 |
_y02-23-2016 _zafifah |
|
| 040 |
_aUkCbUP _cUkCbUP _erda |
||
| 245 | 0 | 0 |
_aEssential CNS Drug Development / _cEdited by Amir Kalali, Sheldon Preskorn, Joseph Kwentus, Stephen M. Stahl. |
| 264 | 1 |
_aCambridge : _bCambridge University Press, _c2012. |
|
| 300 |
_a1 online resource (215 pages) : _bdigital, PDF file(s). |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aTitle from publisher's bibliographic system (viewed on 28 Apr 2015). | ||
| 650 | 0 |
_aCentral Nervous System Agents _xpharmacology. |
|
| 650 | 0 |
_aClinical Trials as Topic _xmethods. |
|
| 650 | 0 |
_aDrug evaluation _xMethods. |
|
| 650 | 0 |
_aDrug Evaluation, Preclinical _xmethods. |
|
| 700 | 1 |
_aKalali, Amir, _eeditor of compilation. |
|
| 700 | 1 |
_aPreskorn, Sheldon, _eeditor of compilation. |
|
| 700 | 1 |
_aKwentus, Joseph, _eeditor of compilation. |
|
| 700 | 1 |
_aStahl, Stephen M., _eeditor of compilation. |
|
| 776 | 0 | 8 |
_iPrint version: _z9780521766067 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1017/CBO9780511977640 |
| 907 |
_a.b16278173 _b2019-11-14 _c2019-11-12 |
||
| 942 | _n0 | ||
| 914 | _avtls003600941 | ||
| 998 |
_anone _b2016-10-02 _cm _da _feng _genk _y0 _z.b16278173 |
||
| 999 |
_c605440 _d605440 |
||